🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for FemTech

Benchmark revenue and EBITDA valuation multiples for public comps like Abbott India, Hologic, Curves Holdings Co., Neurocrine Biosciences and Veru.

Company	EV	EV/Revenue	EV/EBITDA
Hologic	$14.8B	3.6x	11.1x
Neurocrine Biosciences	$11.7B	4.7x	18.6x
Organon	$10.8B	1.7x	5.5x
Abbott India	$7.2B	9.5x	35.6x
Curves Holdings Co.	$423M	1.6x	7.4x
InMode	$386M	1.0x	3.2x
Jiangsu Bioperfectus	$334M	n/a	n/a
Elutia	$81.7M	3.1x	-6.6x
Veru	$57.9M	10.6x	n/a
Applied BioCode	$47.3M	n/a	n/a
Atossa Therapeutics	$35.3M	n/a	n/a
Futura Medical	$28.7M	2.1x	-35.4x
Dare Bioscience	$19.5M	41.6x	n/a
Movano	-$3.9M	-0.6x	n/a
Olema Pharmaceuticals	-$30.3M	n/a	0.2x
Context Therapeutics	-$37.0M	n/a	n/a